Imaging of endolymphatic and perilymphatic fluid after intravenous administration of single-dose gadodiamide

Magnetic Resonance in Medical Sciences

Volumn 11, Issue 2, 2012, Pages 145-150

  Naganawa, Shinji ^a   Yamazaki, Masahiro ^a   Kawai, Hisashi ^a   Bokura, Kiminori ^a   Sone, Michihiko ^a   Nakashima, Tsutomu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

3D imaging; Intravenous; Magnetic resonance imaging; M ni re's disease

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADODIAMIDE; GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CYTOLOGY; ENDOLYMPH; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENIERE DISEASE; MIDDLE AGED; PATHOLOGY; PERILYMPH; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CONTRAST MEDIA; ENDOLYMPH; GADOLINIUM DTPA; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MENIERE DISEASE; MIDDLE AGED; PERILYMPH; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84863854391     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.11.145     Document Type: Article

References (10)

1. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Ménière's disease. Laryngoscope 2007; 117: 415-420.
2. Naganawa S, Sugiura M, Kawamura M, Fukatsu H, Sone M, Nakashima T. Imaging of endolym-phatic and perilymphatic fluid at 3T after intratym-panic administration of gadolinium-diethylene-triamine pentaacetic acid. AJNR Am J Neuro-radiol 2008; 29:724-726.
3. Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Visualization of endolym-phatic hydrops in Ménière's disease with single-dose intravenous gadolinium-based contrast media using heavily T2-weighted 3D-FLAIR. Magn Res-on Med Sci 2010; 9:237-242.
4. Nakashima T, Naganawa S, Pyykko I, et al. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009 Feb; (560):5-8.
5. Tanigawa T, Tamaki T, Yamamuro O, et al. Visualization of endolymphatic hydrops after administration of a standard dose of an intravenous gadolinium-based contrast agent. Acta Otolaryn-gol 2011; 131:596-601.
6. Naganawa S, Kawai H, Sone M, Nakashima T. Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. Magn Reson Med Sci 2010; 9:73-80.
7. Gurkov R, Flatz W, Louza J, Strupp M, Krause E. In vivo visualization of endoly[m]phatic hydrops in patients with Ménière's disease: correlation with audiovestibular function. Eur Arch Otorhino-laryngol 2011; 268:1743-1748.
8. Yamamoto M, Teranishi M, Naganawa S, et al. Relationship between the degree of endolymphatic hydrops and electrocochleography. Audiol Neuro-otol 2010; 15:254-260.
9. Katayama N, Yamamoto M, Teranishi M, et al. Relationship between endolymphatic hydrops and vestibular-evoked myogenic potential. Acta Oto-laryngol 2010; 130:917-923.
10. Nakashima T, Naganawa S, Teranishi M, et al. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière's disease. Acta Otolaryngol 2010; 130:338-343.